
Combination Product:
Diclofenac Potassium + Paracetamol (Acetaminophen)
Common proposed strengths: Diclofenac Potassium 50 mg + Paracetamol 325 mg / 500 mg, subject to the specific registered formulation.
Other Diclofenac Sodium formulations supplied separately:
Diclofenac Sodium BP 25 mg film-coated tablet
Diclofenac Sodium BP/IP 50 mg enteric-coated tablet
Diclofenac Sodium BP 50 mg + Paracetamol BP 500 mg combination
Diclofenac Sodium BP 100 mg film-coated tablet
Usage: Relief of pain and inflammation where an NSAID/analgesic combination is clinically appropriate
Category: Analgesic / Painkiller Drugs
Therapeutic Category: NSAID / Analgesic / Arthritis
SKU: Diclofenac Potassium & Paracetamol Tablets
Categories: Contract Manufacturer, Formulations Exporter India, Manufacturing Pharmaceutical Company India, Pharmaceutical Exporter India, Pharmaceutical Formulations India, Tablets Manufacturer, WHO GMP Certified Formulations
Diclofenac Potassium & Paracetamol Tablets is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.
For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.
Manufactured by: Healthy Life Pharma Pvt. Ltd.
Exported by: Healthy Inc
Healthy Life Pharma Pvt. Ltd. manufactures Diclofenac and Paracetamol tablet formulations in India. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID), while Paracetamol (Acetaminophen) is an analgesic and antipyretic. Combination products may be used for short-term pain management where both components are clinically appropriate. Diclofenac potassium and diclofenac sodium are different salt forms and should not be described interchangeably; the exact salt and strength must match the registered product label.
| Parameter | Specification |
|---|---|
| Product Name | Diclofenac Potassium & Paracetamol Tablets |
| Generic Name | Diclofenac Potassium + Paracetamol (Acetaminophen) |
| Typical Combination Strength | Diclofenac Potassium 50mg + Paracetamol 325mg / 500mg, subject to registered formulation |
| Other Supplied Diclofenac Forms | Diclofenac Sodium 25mg / 50mg / 100mg and Diclofenac Sodium 50mg + Paracetamol 500mg, as separate formulations |
| Dosage Form | Film-coated / other registered tablet presentation |
| Standard | BP / IP / USP / approved in-house specification, as applicable |
| Therapeutic Class | NSAID + Analgesic / Antipyretic |
| Shelf Life | According to validated stability data and registered specification |
| Packaging | Blister / Alu-Alu / authorized bulk pack according to registration |
Diclofenac reduces prostaglandin synthesis through cyclooxygenase inhibition, providing analgesic and anti-inflammatory effects. Paracetamol provides analgesic and antipyretic activity through predominantly central mechanisms.
Q: Who manufactures Diclofenac & Paracetamol Tablets?
A: Healthy Life Pharma Pvt. Ltd. manufactures Diclofenac-based tablet formulations in India.
Q: Are Diclofenac Potassium and Diclofenac Sodium the same?
A: They contain the same active Diclofenac moiety but are different salt forms with different formulation characteristics. The salt stated on the registered label must be used; they should not be silently substituted in product specifications.
Q: Can other Paracetamol medicines be taken at the same time?
A: Taking multiple Paracetamol/Acetaminophen-containing products can unintentionally exceed the recommended total dose and cause serious liver injury. Check all medicine labels and follow clinician/pharmacist advice.
Q: Is this suitable for long-term pain treatment?
A: Diclofenac-containing products should generally be used at the lowest effective dose for the shortest appropriate duration. Longer treatment requires individualized assessment of gastrointestinal, cardiovascular, renal and other risks.
(For Registered Medical Practitioners & Patient Reference)